RBC Capital Markets Cuts Puma Biotechnology Inc (PBYI) Price Target to $17.00 – The Cerbat Gem

Posted: Published on March 7th, 2017

This post was added by Dr P. Richardson


Benzinga
RBC Capital Markets Cuts Puma Biotechnology Inc (PBYI) Price Target to $17.00
The Cerbat Gem
Puma Biotechnology Inc logo Puma Biotechnology Inc (NYSE:PBYI) had its target price reduced by RBC Capital Markets from $48.00 to $17.00 in a research note issued to investors on Thursday morning. They currently have a sector perform rating on the ...
The Puma Biotechnology Inc (PBYI) Price Target Cut to $17.00 by Analysts at RBC Capital MarketsDailyQuint
Puma Biotechnology Shares Plunge On Plans To Modify Neratinib European MAA, Competitor Roche's Perjeta WinBenzinga
Puma Biotechnology Inc Realized Volatility Hits A Notable HighCML News
Smarter Analyst -Yahoo Finance -Sports Perspectives
all 94 news articles »

Go here to read the rest:
RBC Capital Markets Cuts Puma Biotechnology Inc (PBYI) Price Target to $17.00 - The Cerbat Gem

Related Posts
This entry was posted in Biotechnology. Bookmark the permalink.

Comments are closed.